In Situハイブリダイゼーションの市場規模、シェア、動向分析レポート：技術別、プローブタイプ別、製品タイプ別、用途別、最終用途別、地域別、セグメント予測、2024年～2030年

In Situハイブリダイゼーション市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のIn Situハイブリダイゼーションの市場規模は、予測期間中にCAGR 7.2％を記録し、2030年までに25億5,000万米ドルに達すると予測されています。

In Situハイブリダイゼーション（ISH）は、診断の研究および臨床応用に広く利用されています。ISHは、特定の核酸の分布と標的遺伝子タンパク質産物との関係を決定するのに役立つため、研究者の間で人気のあるアプローチです。それゆえ、ISHの応用範囲の拡大は加速しており、さらなる研究につながっています。

ISH技術とその使用法についての認識が高まるにつれ、研究者は様々な用途にISH技術を採用するようになります。例えば、MultiplexDXのCEOはElsevierとのインタビューで、FISH技術は早期薬剤開発や個別化治療のための画期的な情報に貢献できると述べています。先進国では意識の高まりから個別化治療を選択する人が増えており、市場の需要を押し上げています。

さらに、新興経済諸国では保険償還制度が利用できるようになり、この診断に対する需要が増加しています。最近の保険適用拡大により、国民の大多数が治療を受けられるようになったため、需要は増加の一途をたどっています。例えば、米国ではMedicareが最大の市場プレイヤーであり、所得や病歴に関係なく65歳以上の高齢者に治療を提供しています。

COVID-19の大流行により、さまざまな研究者がCOVID-19感染細胞にISH技術を採用したため、需要側はISH市場にプラスの影響を示しました。2020年7月に発表された調査では、COVID-19感染患者の剖検肺8例、腎生検10例、胎盤1例をISHアッセイとRNAプローブで検討しました。

COVID-19陽性の結果は、ISHによって8つの肺すべてと胎盤で示されましたが、腎臓サンプルでは示されませんでした。このアッセイは、組織サンプルからウイルスを検出する高感度で特異的な技術を示すものです。同様に、Advanced Cell Diagnostics, Inc.はCOVID-19研究をサポートするRNAscope技術を導入しました。

各社の戦略的イニシアチブの高まりがISH市場の成長を後押しすると予想されます。主要企業はポートフォリオを強化するため、市場に新製品を投入しています。例えば、F. Hoffmann-La Rocheは2021年3月、In Situハイブリダイゼーションと免疫組織化学の多重化機能を拡張するDISCOVERY Green HRP発色検出キットを発売しました。

一方、分子診断学は正確で効果的な結果を提供し、診断の分野で不可欠なアプリケーションです。しかし、FISHアッセイの製造コストが高く、FISHイメージングに使用される専門的な組立工場や機器のメンテナンスに必要な資本が高額であるため、収益創出が制限される可能性が高いです。

In Situハイブリダイゼーション市場レポート・ハイライト

• 技術別では、CISH分野が予測期間中に最も速い成長率で拡大すると予測されます。CISHで使用される試薬はより安定しているため、サンプルはより長期間保存でき、複数回の検査が可能です。
• プローブ別では、DNA分野が予測期間中に最も速い成長率を示すと予測されています。遺伝子異常やがんなど、染色体異常に関連する疾患の発生率が増加しているためです。
• 製品別では、サービス分野が2024年から2030年にかけてCAGRが最も急速に伸びると予測されています。品質基準を確実に守り、業務機能を向上させるためのアウトソーシングの増加が、有利な成長に寄与しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

• 市場セグメンテーションと範囲
• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場動向と展望
• 市場力学
  • 対象疾患の有病率の上昇
  • 体外診断分野における技術の進歩
  • 体外診断における研究開発投資の増加
• 市場抑制要因分析
  • ISHのコストが高い
  • 曖昧な規制枠組みの存在
• 2023年の普及と成長の見通しマッピング
• 事業環境分析
  • SWOT分析；要因別（政治・法律、経済・技術）
  • ポーターのファイブフォース分析

第4章 テクノロジービジネス分析

• In Situハイブリダイゼーション市場：製品タイプの変動分析
• FISH
  • FISH市場、2018年～2030年
• CISH
  • CISH市場、2018年～2030年

第5章 プローブビジネス分析

• In Situハイブリダイゼーション市場：サイト変動分析
• DNA
  • DNA市場、2018年～2030年
• RNA
  • RNA市場、2018年～2030年

第6章 製品ビジネス分析

• In Situハイブリダイゼーション市場：サイト変動分析
• 機器
  • 機器市場、2018年～2030年
• 消耗品と付属品
  • 消耗品と付属品市場、2018年～2030年
• ソフトウェア
  • ソフトウェア市場、2018年～2030年
• サービス
  • サービス市場、2018年～2030年

第7章 アプリケーションビジネス分析

• In Situハイブリダイゼーション市場：製品タイプの変動分析
• がん
  • がん市場、2018年～2030年
• 細胞遺伝学
  • 細胞遺伝学市場、2018年～2030年
• 発生生物学
  • 発生生物学市場、2018年～2030年
• 感染症
  • 感染症市場、2018年～2030年
• その他
  • その他市場、2018年～2030年

第8章 最終用途ビジネス分析

• In Situハイブリダイゼーション市場：最終用途の変動分析
• 病院と診断研究所
  • 病院と診断研究所の市場、2018年～2030年
• CRO
  • CRO市場、2018年～2030年
• 学術・研究機関
  • 学術・研究機関の市場、2018年～2030年
• その他
  • その他市場、2018年～2030年

第9章 地域ビジネス分析

• 地域別のIn Situハイブリダイゼーション市場シェア、2023年・2030年
• 北米
  • SWOT分析
  • 北米のIn Situハイブリダイゼーション市場、2018年～2030年
  • 米国
  • カナダ
• 欧州
  • SWOT分析
  • 欧州のIn Situハイブリダイゼーション市場、2018年～2030年
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋地域
  • SWOT分析
  • アジア太平洋地域のIn Situハイブリダイゼーション市場、2018年～2030年
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • SWOT分析
  • ラテンアメリカのIn Situハイブリダイゼーション市場、2018年～2030年
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • SWOT分析
  • 中東・アフリカのIn Situハイブリダイゼーション市場、2018年～2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第10章 競合情勢

• 企業の分類
• 戦略マッピング
  • 新製品の発売
  • パートナーシップ
  • 取得
  • コラボレーション
  • 資金調達
• 主要企業の市場シェア分析、2023年
• 企業ヒートマップ分析
• 企業プロファイル
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific, Inc.
  • BioView
  • Agilent Technologies, Inc.
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • OXFORD GENE TECHNOLOGY IP LIMITED
  • LEICA BIOSYSTEMS NUSSLOCH GMBH（DANAHER CORPORATION）
  • NEOGENOMICS LABORATORIES, INC.
  • ADVANCED CELL DIAGNOSTICS, INC.

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 4 Global In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 5 Global In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 6 Global In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 7 Global In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 8 Global In Situ Hybridization Market, by Region, 2018 - 2030 (USD Million)
• Table 9 North America In Situ Hybridization Market, by Country, 2018 - 2030 (USD Million)
• Table 10 North America In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 11 North America In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 12 North America In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 13 North America In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 14 North America In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 15 U.S. In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 16 U.S. In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 17 U.S. In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 18 U.S. In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 19 U.S. In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 20 Canada In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 21 Canada In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 22 Canada In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 23 Canada In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 24 Canada In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 25 Europe In Situ Hybridization Market, by Country, 2018 - 2030 (USD Million)
• Table 26 Europe In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 27 Europe In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 28 Europe In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 29 Europe In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 30 Europe In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 31 Germany In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 32 Germany In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 33 Germany In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 34 Germany In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 35 Germany In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 36 UK In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 37 UK In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 38 UK In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 39 UK In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 40 UK In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 41 France In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 42 France In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 43 France In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 44 France In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 45 France In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 46 Italy In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 47 Italy In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 48 Italy In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 49 Italy In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 50 Italy In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 51 Spain In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 52 Spain In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 53 Spain In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 54 Spain In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 55 Spain In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 56 Sweden In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 57 Sweden In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 58 Sweden In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 59 Sweden In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 60 Sweden In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 61 Denmark In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 62 Denmark In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 63 Denmark In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 64 Denmark In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 65 Denmark In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 66 Norway In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 67 Norway In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 68 Norway In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 69 Norway In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 70 Norway In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 71 Asia Pacific In Situ Hybridization Market, by Country, 2018 - 2030 (USD Million)
• Table 72 Asia Pacific In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 73 Asia Pacific In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 74 Asia Pacific In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 75 Asia Pacific In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 76 Asia Pacific In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 77 China In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 78 China In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 79 China In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 80 China In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 81 China In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 82 Japan In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 83 Japan In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 84 Japan In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 85 Japan In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 86 Japan In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 87 India In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 88 India In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 89 Indian Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 90 India In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 91 Indian Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 92 South Korea In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 93 South Korea In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 94 South Korean Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 95 South Korea In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 96 South Korean Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 97 Australia In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 98 Australia In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 99 Australia In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 100 Australia In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 101 Australia In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 102 Thailand In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 103 Thailand In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 104 Thailand In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 105 Thailand In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 106 Thailand In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 107 Latin America In Situ Hybridization Market, by Country, 2018 - 2030 (USD Million)
• Table 108 Latin America In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 109 Latin America In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 110 Latin America In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 111 Latin America In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 112 Latin America In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 113 Brazil In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 114 Brazil In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 115 Brazil in Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 116 Brazil In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 117 Brazil In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 118 Mexico In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 119 Mexico In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 120 Mexico In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 121 Mexico In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 122 Mexico In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 123 Argentina In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 124 Argentina In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 125 Argentina In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 126 Argentina In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 127 Argentina In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 128 Middle East & Africa In Situ Hybridization Market, by Country, 2018 - 2030 (USD Million)
• Table 129 Middle East & Africa In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 130 Middle East & Africa In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 131 Middle East & Africa In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 132 Middle East & Africa In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 133 Middle East & Africa In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 134 South Africa In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 135 South Africa In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 136 South Africa In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 137 South Africa In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 138 South Africa In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 139 Saudi Arabia In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 140 Saudi Arabia In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 141 Saudi Arabia In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 142 Saudi Arabia In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 143 Saudi Arabia In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 144 UAE In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 145 UAE In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 146 UAE In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 147 UAE In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 148 UAE In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
• Table 149 Kuwait In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
• Table 150 Kuwait In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
• Table 151 Kuwait In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
• Table 152 Kuwait In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
• Table 153 Kuwait In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million) 

List of Figures

• Fig. 1 In situ hybridization market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation and validation
• Fig. 9 Commodity flow approach
• Fig. 10 Market snapshot (USD Million)
• Fig. 11 Segment snapshot (technology, probe & end-use)
• Fig. 12 Segment snapshot (product & application)
• Fig. 13 Competitive snapshot
• Fig. 14 Market trends & outlook
• Fig. 15 Estimated number of new cases from 2020 to 2040, both sexes, age [0-85+], globally.
• Fig. 16 SWOT analysis, by factor (political & legal, economic, and technological)
• Fig. 17 Porter's five forces analysis
• Fig. 18 In situ hybridization market: Technology type outlook key takeaways (USD Million)
• Fig. 19 In situ hybridization market: Technology type movement analysis
• Fig. 20 In situ hybridization market for FISH, 2018 - 2030 (USD Million)
• Fig. 21 In situ hybridization market for CISH, 2018 - 2030 (USD Million)
• Fig. 22 In situ hybridization market: Probe outlook key takeaways (USD Million)
• Fig. 23 In situ hybridization market: Probe movement analysis
• Fig. 24 In situ hybridization market for DNA, 2018 - 2030 (USD Million)
• Fig. 25 In situ hybridization market for RNA, 2018 - 2030 (USD Million)
• Fig. 26 In situ hybridization market: End-use outlook key takeaways (USD Million)
• Fig. 27 In situ hybridization market: End-use type movement analysis
• Fig. 28 In situ hybridization market for hospital & diagnostics laboratories, 2018 - 2030 (USD Million)
• Fig. 29 In situ hybridization market for CROs, 2018 - 2030 (USD Million)
• Fig. 30 In situ hybridization market for academic institutes, 2018 - 2030 (USD Million)
• Fig. 31 In situ hybridization market for other end-use, 2018 - 2030 (USD Million)
• Fig. 32 In situ hybridization market: Product outlook and key takeaways
• Fig. 33 In situ hybridization market: Product movement analysis
• Fig. 34 In situ hybridization market instruments, 2018 - 2030 (USD Million)
• Fig. 35 In situ hybridization kits and probes market, 2018 - 2030 (USD Million)
• Fig. 36 In situ hybridization software market, 2018 - 2030 (USD Million)
• Fig. 37 In situ hybridization services market, 2018 - 2030 (USD Million)
• Fig. 38 In situ hybridization market: Application outlook and key takeaways
• Fig. 39 In situ hybridization market: Application movement analysis
• Fig. 40 Cancer application for in situ hybridization market, 2018 - 2030 (USD Million)
• Fig. 41 Cytogenetics application for in situ hybridization market, 2018 - 2030 (USD Million)
• Fig. 42 Development biology application for in situ hybridization market, 2018 - 2030 (USD Million)
• Fig. 43 Infectious diseases application for in situ hybridization market, 2018 - 2030 (USD Million)
• Fig. 44 Other applications for in situ hybridization market, 2018 - 2030 (USD Million)
• Fig. 45 In situ hybridization market revenue, by region, 2022 & 2030 (USD Million)
• Fig. 46 Regional marketplace: Key takeaways
• Fig. 47 North America in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Key country dynamics
• Fig. 49 U.S. in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Cancer Incidence, 2018 - 2030
• Fig. 51 Competitive scenario
• Fig. 52 Key country dynamics
• Fig. 53 Canada in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Cancer incidence, 2018 - 2030
• Fig. 55 Competitive scenario
• Fig. 56 Europe in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Key country dynamics
• Fig. 58 UK in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Cancer incidence, 2018 - 2030
• Fig. 60 Competitive scenario
• Fig. 61 Key country dynamics
• Fig. 62 Germany in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Cancer incidence, 2018 - 2030
• Fig. 64 Competitive scenario
• Fig. 65 Key country dynamics
• Fig. 66 France in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Cancer incidence, 2018 - 2030
• Fig. 68 Competitive scenario
• Fig. 69 Key country dynamics
• Fig. 70 Spain in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Cancer incidence, 2018 - 2030
• Fig. 72 Competitive scenario
• Fig. 73 Key country dynamics
• Fig. 74 Italy in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Cancer incidence, 2018 - 2030
• Fig. 76 Competitive scenario
• Fig. 77 Key country dynamics
• Fig. 78 Denmark in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Target disease prevalence
• Fig. 80 Competitive scenario
• Fig. 81 Regulatory framework
• Fig. 82 Key country dynamics
• Fig. 83 Sweden in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 84 Five most common cancers in Sweden
• Fig. 85 Competitive scenario
• Fig. 86 Regulatory framework
• Fig. 87 Key country dynamics
• Fig. 88 Norway in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 89 Number of new cancer cases in 2020, both sexes, all ages
• Fig. 90 Competitive scenario
• Fig. 91 Rest of Europe market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 92 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 93 Key country dynamics
• Fig. 94 Japan in situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 95 Cancer incidence, 2018 to 2030
• Fig. 96 Competitive scenario
• Fig. 97 Key country dynamics
• Fig. 98 China in situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 99 Cancer incidence, 2018 to 2030
• Fig. 100 Competitive scenario
• Fig. 101 Key country dynamics
• Fig. 102 India in situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 103 Cancer incidence, 2018 to 2030
• Fig. 104 Competitive scenario
• Fig. 105 Key country dynamics
• Fig. 106 Australia in situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 107 Cancer incidence, 2018 to 2030
• Fig. 108 Competitive scenario
• Fig. 109 Key country dynamics
• Fig. 110 Thailand in situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 111 Cancer incidence, 2020 to 2030
• Fig. 112 Competitive scenario
• Fig. 113 Key country dynamics
• Fig. 114 South Korea in situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 115 Cancer incidence 2018 to 2030
• Fig. 116 Competitive scenario
• Fig. 117 Rest of Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 118 Latin America in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 119 Key country dynamics
• Fig. 120 Brazil in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 121 Estimated number of new cancer cases in Brazil
• Fig. 122 Competitive scenario
• Fig. 123 Key country dynamics
• Fig. 124 Mexico in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 125 Estimated number of new cancer cases in Mexico
• Fig. 126 Competitive scenario
• Fig. 127 Key country dynamics
• Fig. 128 Argentina in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 129 Estimated number of new cancer cases in Argentina
• Fig. 130 Competitive scenario
• Fig. 131 Rest of LATAM market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 132 MEA in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 133 Key country dynamics
• Fig. 134 South Africa in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 135 Cancer prevalence-2018 - 2030
• Fig. 136 Competitive scenario
• Fig. 137 Key country dynamics
• Fig. 138 Saudi Arabia in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 139 Cancer prevalence-2018 - 2030
• Fig. 140 Competitive scenario
• Fig. 141 Key country dynamics
• Fig. 142 UAE in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 143 Cancer prevalence 2018 - 2030
• Fig. 144 Competitive scenario
• Fig. 145 Key country dynamics
• Fig. 146 Kuwait in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 147 Target disease prevalence
• Fig. 148 Competitive scenario
• Fig. 149 Key payors in Kuwait
• Fig. 150 Rest of MEA market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 151 Market participant categorization
• Fig. 152 In situ hybridization market share analysis, 2022
• Fig. 153 Strategic framework
• Fig. 154 Ansoff Matrix
• Fig. 155 Competition categorization
• Fig. 156 Company market position analysis (Diagnostics)
• Fig. 157 Company market position analysis

In Situ Hybridization Market Growth & Trends:

The global in situ hybridization market size is expected to reach USD 2.55 billion by 2030, registering a CAGR of 7.2% during the forecast period, according to a new report by Grand View Research, Inc. Situ Hybridization (ISH) is extensively utilized for research and clinical applications of diagnostics. ISH is a popular approach among researchers as it aids in determining the relationship between the distribution of specific nucleic acids and the target gene protein products. Hence, expanding the scope of ISH in applications is accelerating and leading to further research.

The increasing awareness about ISH techniques and their usage encourages researchers to employ the techniques for various applications. For instance, the CEO of MultiplexDX stated in an interview with Elsevier that FISH technology can contribute breakthrough information for early drug development and personalized treatment. A growing number of people in developed countries are opting for personalized treatment owing to an increase in awareness, thus boosting market demand.

Furthermore, reimbursement schemes being made available in developed economies have led to an increase in demand for this diagnosis. The demand continues to increase as the majority of the public can now afford it due to the recent expansion through insurance coverage. For instance, Medicare is the largest market player in the U.S., which provides care for those aged 65 years and above, irrespective of their income and medical history.

Owing to the COVID-19 pandemic, the demand side showcased a positive impact on the ISH market as various researchers employed the technique on COVID-19-infected cells. Research published in July 2020, considered 8 autopsy lungs, 10 kidney biopsies, and 1 placenta from COVID-19-infected patients with ISH assay and RNA probes.

COVID-19 positive results showed in all 8 lungs and the placenta by ISH, but not in the kidney samples. The assay showcases a sensitive and specific technique for detecting the virus from tissue samples. Similarly, Advanced Cell Diagnostics, Inc., introduced RNAscope technology to support COVID-19 research.

The growing strategic initiatives by the companies are anticipated to boost the ISH market growth. Key players are introducing novel products in the market to strengthen their portfolios. For instance, in March 2021, F. Hoffmann-La Roche launched DISCOVERY Green HRP chromogen detection kit to expand the multiplexing capability of in situ hybridization and immunohistochemistry.

On the other hand, molecular diagnostics renders accurate & effective results and has indispensable applications in the field of diagnosis. However, the high manufacturing cost of FISH assays and the high amount of capital required for specialized assembly plants & maintenance of instruments used in FISH imaging are likely to limit revenue generation.

In Situ Hybridization Market Report Highlights:

• By technology, the CISH segment is projected to expand at the fastest growth rate during the forecast period. Since the reagents used in CISH are more stable, the sample can be stored for a longer duration and can be examined multiple times
• By probe, the DNA segment is anticipated to have the fastest growth rate during the forecast period. Owing to the increasing incidence of diseases associated with chromosomal aberrations, such as genetic abnormalities and cancer
• By product, the services segment is anticipated to have the fastest-growing CAGR between 2024 to 2030. Increasing outsourcing to ensure high adherence to quality standards and improve operational functionalities contributes to the lucrative growth.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation
  • 1.1.1. Market Definitions
• 1.2. Objectives
  • 1.2.1. Objective - 1
  • 1.2.2. Objective - 2
  • 1.2.3. Objective - 3
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Trends and Outlook
• 3.4. Market Dynamics
  • 3.4.1. Rising Prevalence of Target Disorders
  • 3.4.2. Technological Advancement In the Field of In Vitro Diagnostics
  • 3.4.3. Increasing R&D Investments In In Vitro Diagnostics
• 3.5. Market Restraint Analysis
  • 3.5.1. High Cost of ISH
  • 3.5.2. Presence of An Ambiguous Regulatory Framework
• 3.6. Penetration and Growth Prospect Mapping 2023
• 3.7. Business Environment Analysis
  • 3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
  • 3.7.2. Porter's Five Forces Analysis

Chapter 4. Technology Business Analysis

• 4.1. In Situ Hybridization Market: Product Type Movement Analysis
• 4.2. FISH
  • 4.2.1. FISH Market, 2018 - 2030 (USD Million)
• 4.3. CISH
  • 4.3.1. CISH Market, 2018 - 2030 (USD Million)

Chapter 5. Probe Business Analysis

• 5.1. In Situ Hybridization Market: Site Movement Analysis
• 5.2. DNA
  • 5.2.1. DNA Market, 2018 - 2030 (USD Million)
• 5.3. RNA
  • 5.3.1. RNA Market, 2018 - 2030 (USD Million)

Chapter 6. Product Business Analysis

• 6.1. In Situ Hybridization Market: Site Movement Analysis
• 6.2. Instruments
  • 6.2.1. Instruments Market, 2018 - 2030 (USD Million)
• 6.3. Consumables & Accessories
  • 6.3.1. Consumables & Accessories Market, 2018 - 2030 (USD Million)
• 6.4. Software
  • 6.4.1. Software Market, 2018 - 2030 (USD Million)
• 6.5. Services
  • 6.5.1. Services Market, 2018 - 2030 (USD Million)

Chapter 7. Application Business Analysis

• 7.1. In Situ Hybridization Market: Product Type Movement Analysis
• 7.2. Cancer
  • 7.2.1. Cancer Market, 2018 - 2030 (USD Million)
• 7.3. Cytogenetics
  • 7.3.1. Cytogenetics Market, 2018 - 2030 (USD Million)
• 7.4. Developmental Biology
  • 7.4.1. Developmental Biology Market, 2018 - 2030 (USD Million)
• 7.5. Infectious Diseases
  • 7.5.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
• 7.6. Others
  • 7.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. End-use Business Analysis

• 8.1. In Situ Hybridization Market: End-use Movement Analysis
• 8.2. Hospitals & Diagnostic Laboratories
  • 8.2.1. Hospitals & Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
• 8.3. CROs
  • 8.3.1. CROs Market, 2018 - 2030 (USD Million)
• 8.4. Academic & Research Institutes
  • 8.4.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
• 8.5. Others
  • 8.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 9. Regional Business Analysis

• 9.1. In Situ Hybridization Market Share By Region, 2023 & 2030
• 9.2. North America
  • 9.2.1. SWOT Analysis
  • 9.2.2. North America In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.2.3. U.S.
    • 9.2.3.1. Key Country Dynamics
    • 9.2.3.2. Target Disease Scenario
    • 9.2.3.3. Competitive Scenario
    • 9.2.3.4. Regulatory Framework
    • 9.2.3.5. Reimbursement Scenario
    • 9.2.3.6. U.S. In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.2.4. Canada
    • 9.2.4.1. Key Country Dynamics
    • 9.2.4.2. Target Disease Scenario
    • 9.2.4.3. Competitive Scenario
    • 9.2.4.4. Regulatory Framework
    • 9.2.4.5. Reimbursement Scenario
    • 9.2.4.6. Canada In Situ Hybridization Market, 2018 - 2030 (USD Million)
• 9.3. Europe
  • 9.3.1. SWOT Analysis
  • 9.3.2. Europe In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.3.3. Germany
    • 9.3.3.1. Key Country Dynamics
    • 9.3.3.2. Target Disease Scenario
    • 9.3.3.3. Competitive Scenario
    • 9.3.3.4. Regulatory Framework
    • 9.3.3.5. Reimbursement Scenario
    • 9.3.3.6. Germany In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.3.4. UK
    • 9.3.4.1. Key Country Dynamics
    • 9.3.4.2. Target Disease Scenario
    • 9.3.4.3. Competitive Scenario
    • 9.3.4.4. Regulatory Framework
    • 9.3.4.5. Reimbursement Scenario
    • 9.3.4.6. UK In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.3.5. France
    • 9.3.5.1. Key Country Dynamics
    • 9.3.5.2. Target Disease Scenario
    • 9.3.5.3. Competitive Scenario
    • 9.3.5.4. Regulatory Framework
    • 9.3.5.5. Reimbursement Scenario
    • 9.3.5.6. France In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.3.6. Italy
    • 9.3.6.1. Key Country Dynamics
    • 9.3.6.2. Target Disease Scenario
    • 9.3.6.3. Competitive Scenario
    • 9.3.6.4. Regulatory Framework
    • 9.3.6.5. Reimbursement Scenario
    • 9.3.6.6. Italy In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.3.7. Spain
    • 9.3.7.1. Key Country Dynamics
    • 9.3.7.2. Target Disease Scenario
    • 9.3.7.3. Competitive Scenario
    • 9.3.7.4. Regulatory Framework
    • 9.3.7.5. Reimbursement Scenario
    • 9.3.7.6. Spain In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.3.8. Denmark
    • 9.3.8.1. Key Country Dynamics
    • 9.3.8.2. Target Disease Scenario
    • 9.3.8.3. Competitive Scenario
    • 9.3.8.4. Regulatory Framework
    • 9.3.8.5. Reimbursement Scenario
    • 9.3.8.6. Denmark In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.3.9. Sweden
    • 9.3.9.1. Key Country Dynamics
    • 9.3.9.2. Target Disease Scenario
    • 9.3.9.3. Competitive Scenario
    • 9.3.9.4. Regulatory Framework
    • 9.3.9.5. Reimbursement Scenario
    • 9.3.9.6. Sweden In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.3.10. Norway
    • 9.3.10.1. Key Country Dynamics
    • 9.3.10.2. Target Disease Scenario
    • 9.3.10.3. Competitive Scenario
    • 9.3.10.4. Regulatory Framework
    • 9.3.10.5. Reimbursement Scenario
    • 9.3.10.6. Norway In Situ Hybridization Market, 2018 - 2030 (USD Million)
• 9.4. Asia Pacific
  • 9.4.1. SWOT Analysis
  • 9.4.2. Asia Pacific In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.4.3. Japan
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Target Disease Scenario
    • 9.4.3.3. Competitive Scenario
    • 9.4.3.4. Regulatory Framework
    • 9.4.3.5. Reimbursement Scenario
    • 9.4.3.6. Japan In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.4.4. China
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Target Disease Scenario
    • 9.4.4.3. Competitive Scenario
    • 9.4.4.4. Regulatory Framework
    • 9.4.4.5. Reimbursement Scenario
    • 9.4.4.6. China In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.4.5. India
    • 9.4.5.1. Key Country Dynamics
    • 9.4.5.2. Target Disease Scenario
    • 9.4.5.3. Competitive Scenario
    • 9.4.5.4. Regulatory Framework
    • 9.4.5.5. Reimbursement Scenario
    • 9.4.5.6. India In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.4.6. South Korea
    • 9.4.6.1. Key Country Dynamics
    • 9.4.6.2. Target Disease Scenario
    • 9.4.6.3. Competitive Scenario
    • 9.4.6.4. Regulatory Framework
    • 9.4.6.5. Reimbursement Scenario
    • 9.4.6.6. South Korea In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.4.7. Australia
    • 9.4.7.1. Key Country Dynamics
    • 9.4.7.2. Target Disease Scenario
    • 9.4.7.3. Competitive Scenario
    • 9.4.7.4. Regulatory Framework
    • 9.4.7.5. Reimbursement Scenario
    • 9.4.7.6. Australia In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.4.8. Thailand
    • 9.4.8.1. Key Country Dynamics
    • 9.4.8.2. Target Disease Scenario
    • 9.4.8.3. Competitive Scenario
    • 9.4.8.4. Regulatory Framework
    • 9.4.8.5. Reimbursement Scenario
    • 9.4.8.6. Thailand In Situ Hybridization Market, 2018 - 2030 (USD Million)
• 9.5. Latin America
  • 9.5.1. SWOT Analysis
  • 9.5.2. Latin America In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.5.3. Brazil
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Target Disease Scenario
    • 9.5.3.3. Competitive Scenario
    • 9.5.3.4. Regulatory Framework
    • 9.5.3.5. Reimbursement Scenario
    • 9.5.3.6. Brazil In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.5.4. Mexico
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Target Disease Scenario
    • 9.5.4.3. Competitive Scenario
    • 9.5.4.4. Regulatory Framework
    • 9.5.4.5. Reimbursement Scenario
    • 9.5.4.6. Mexico In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.5.5. Argentina
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Target Disease Scenario
    • 9.5.5.3. Competitive Scenario
    • 9.5.5.4. Regulatory Framework
    • 9.5.5.5. Reimbursement Scenario
    • 9.5.5.6. Argentina In Situ Hybridization Market, 2018 - 2030 (USD Million)
• 9.6. MEA
  • 9.6.1. SWOT Analysis
  • 9.6.2. MEA In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.6.3. South Africa
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Target Disease Scenario
    • 9.6.3.3. Competitive Scenario
    • 9.6.3.4. Regulatory Framework
    • 9.6.3.5. Reimbursement Scenario
    • 9.6.3.6. South Africa In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.6.4. Saudi Arabia
    • 9.6.4.1. Key Country Dynamics
    • 9.6.4.2. Target Disease Scenario
    • 9.6.4.3. Competitive Scenario
    • 9.6.4.4. Regulatory Framework
    • 9.6.4.5. Reimbursement Scenario
    • 9.6.4.6. Saudi Arabia In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.6.5. UAE
    • 9.6.5.1. Key Country Dynamics
    • 9.6.5.2. Target Disease Scenario
    • 9.6.5.3. Competitive Scenario
    • 9.6.5.4. Regulatory Framework
    • 9.6.5.5. Reimbursement Scenario
    • 9.6.5.6. UAE In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.6.6. Kuwait
    • 9.6.6.1. Key Country Dynamics
    • 9.6.6.2. Target Disease Scenario
    • 9.6.6.3. Competitive Scenario
    • 9.6.6.4. Regulatory Framework
    • 9.6.6.5. Reimbursement Scenario
    • 9.6.6.6. Kuwait In Situ Hybridization Market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Company Categorization
• 10.2. Strategy Mapping
  • 10.2.1. New Product Launch
  • 10.2.2. Partnerships
  • 10.2.3. Acquisition
  • 10.2.4. Collaboration
  • 10.2.5. Funding
• 10.3. Key Company Market Share Analysis, 2023
• 10.4. Company Heat Map Analysis
• 10.5. Company Profiles
  • 10.5.1. . PerkinElmer, Inc.
    • 10.5.1.1. Company Overview
    • 10.5.1.2. Financial Performance
    • 10.5.1.3. Product Benchmarking
    • 10.5.1.4. Strategic Initiatives
  • 10.5.2. Thermo Fisher Scientific, Inc.
    • 10.5.2.1. Company Overview
    • 10.5.2.2. Financial Performance
    • 10.5.2.3. Product Benchmarking
    • 10.5.2.4. Strategic Initiatives
  • 10.5.3. BioView
    • 10.5.3.1. Company Overview
    • 10.5.3.2. Financial Performance
    • 10.5.3.3. Product Benchmarking
    • 10.5.3.4. Strategic Initiatives
  • 10.5.4. Agilent Technologies, Inc.
    • 10.5.4.1. Company Overview
    • 10.5.4.2. Financial Performance
    • 10.5.4.3. Product Benchmarking
    • 10.5.4.4. Strategic Initiatives
  • 10.5.5. Merck KGaA
    • 10.5.5.1. Company Overview
    • 10.5.5.2. Financial Performance
    • 10.5.5.3. Product Benchmarking
    • 10.5.5.4. Strategic Initiatives
  • 10.5.6. Bio-Rad Laboratories, Inc.
    • 10.5.6.1. Company Overview
    • 10.5.6.2. Financial Performance
    • 10.5.6.3. Product Benchmarking
    • 10.5.6.4. Strategic Initiatives
  • 10.5.7. OXFORD GENE TECHNOLOGY IP LIMITED
    • 10.5.7.1. Financial Performance
    • 10.5.7.2. Product Benchmarking
    • 10.5.7.3. Strategic Initiatives
  • 10.5.8. LEICA BIOSYSTEMS NUSSLOCH GMBH (DANAHER CORPORATION)
    • 10.5.8.1. Company Overview
    • 10.5.8.2. Financial Performance
    • 10.5.8.3. Product Benchmarking
    • 10.5.8.4. Strategic Initiatives
  • 10.5.9. NEOGENOMICS LABORATORIES, INC.
    • 10.5.9.1. Financial Performance
    • 10.5.9.2. Product Benchmarking
    • 10.5.9.3. Strategic Initiatives
  • 10.5.10. ADVANCED CELL DIAGNOSTICS, INC.
    • 10.5.10.1. Company Overview
    • 10.5.10.2. Financial Performance
    • 10.5.10.3. Product Benchmarking
    • 10.5.10.4. Strategic Initiatives